appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Dr Reddy's Laboratories Ltd
DRREDDY
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.
Brands
Brands
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Taking Stock: Nifty falls 105 points from day’s high to end flat as banks underperform
3 weeks ago•Moneycontrol
Trade setup for Thursday: Top 15 things to know before the opening bell
1 month ago•Moneycontrol
Dr Reddy’s Laboratories, Indian Bank and 4 other BSE 200 stocks hit new 52-week high
1 month ago•Economic Times
Auto, pharma stocks offering margin of safety top funds’ buy list in July
1 month ago•Economic Times
Breakout Stocks: How are NLC India, Ircon International and Dr Reddy’s Labs looking on charts for Thursday?
1 month ago•Economic Times
Taking Stock: Last-hour buying pushes Nifty above 19,600, Sensex up 149 points
1 month ago•Moneycontrol
Neutral Dr Reddy’s Labs; target of Rs 5240: Motilal Oswal
1 month ago•Moneycontrol
Zomato, Bharat Forge, 6 other BSE100 stocks hit 52-week highs on Friday
1 month ago•Economic Times
Recent EventsAll events
Board Meeting Intimation
DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Download
DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 . | Download
Loss of Share Certificates
Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced | Download
Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced | Download
Cash Dividend
Final • Div/Share: ₹ 40
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant